Diseases (A-Z)

Conditions such as eczema, contact dermatitis, allergy-induced asthma and hay fever are all connected to allergy.

La Jolla Institute scientists are working to understand how the body's T cells may target the proteins involved in the plaques and tangles seen in brains with Alzheimer's disease.

Asthma affects more than 25 million people across the nation—7 million of them children—and the incidence is rising.

Atopic dermatitis occurs when a person’s immune system causes inflammation of the skin, which also makes the skin more vulnerable to environmental irritants and allergens.

Scientists at La Jolla Institute are investigating what causes immune cells to turn on the body—and how we can intervene.

One in four deaths in the United States is caused by cancer. Scientists at La Jolla Institute for Immunology (LJI) are committed to making cancer immunotherapies work for more people.

Researchers at La Jolla Institute for Immunology (LJI) are investigating how CHIKV infects cells and how the immune system responds to a CHIKV attack.

CMV is the number one infectious cause of congenital birth defects worldwide. Researchers at La Jolla Institute are working to define the molecular underpinnings of CMV infection.

Scientists in the La Jolla Institute for Immunology (LJI) remain at the forefront of research into COVID-19 vaccines, therapies, and the disease's long-term effects.

Dengue fever is the world’s most common mosquito-borne disease, giving rise to 390 million cases of viral disease yearly in tropical regions of Africa, Latin America, and Asia.

Ebola, which is endemic to west and central Africa, gives rise to hemorrhagic fever, vomiting, diarrhea, and muscle pain.

Fibrosis occurs when immune cells mistakenly attack these connective tissues, causing the tissues to thicken and scar.

Allergens like egg, shellfish, or peanut proteins stimulate white blood cells to dump excessive quantities of immune molecules into the blood, triggering inflammation.

Scientists have found that immune cells play a role in the development of several types of cardiovascular diseases.

La Jolla Institute scientists are working to help develop an HIV/AIDS vaccine that can stimulate the immune system to neutralize many strains of the virus.

Researchers at La Jolla Institute are working to prevent the symptoms of IBD before inflammation escalates.

More than 3 billion people are at risk of Japanese encephalitis, a viral disease that sickens an estimated 68,000 people each year, killing up to 20,400.

Lassa virus is endemic to West Africa and kills nearly 5,000 people a year. Research led by La Jolla Institute scientists lays the groundwork for anti-Lassa vaccine development.

Lung cancer is the leading cause of cancer death for both men and women in the United States. Researchers at La Jolla Institute for Immunology are studying ways to halt lung cancer growth.

LJI scientists are working to improve vaccines and therapies against measles and related paramyxoviruses.

LJI scientists are committed to better understanding how the human immune system targets mpox—and how vaccines can protect at-risk people. 

Nipah virus is endemic to regions of Southeast Asia, India, and Bangladesh, and kills 40–70  percent of those infected.

Researchers at La Jolla Institute are investigating how the immune system may contribute to Parkinson's disease.

Scientists at La Jolla Institute for Immunology (LJI) direct cutting-edge research into how the body's immune cells recognize and fight S. pneumoniae infection.

Powassan is a blood-borne virus spread by ticks. Cases are rare, but cases-per-year have increased sharply in the last decade.

Millions of people suffer from seasonal allergies. For them, the onset of spring signals several months of misery.

Strep throat is one of a several conditions, among them pneumonia, scarlet fever, impetigo, and flesh-eating necrotizing fasciitis, caused by the bacterium Streptococcus pyogenes.

Tuberculosis kills more people each year than any other infectious disease. Scientists at La Jolla Institute are working to help doctors treat those at most risk—sooner.

Type 1 diabetes accounts for up to 2 million U.S. cases and occurs when the immune system mistakenly destroys insulin-producing cells in the pancreas.

Vasculitis is the umbrella term for nearly 20 rare diseases all associated with inflammation of the blood vessels.

This extremely contagious disease is caused by the bacterium Bordetella pertussis, and it can be fatal in newborns.

Yellow fever is an infectious disease caused by the mosquito-borne yellow fever virus. This virus is a kind of flavivirus and is closely related to dengue virus, Zika virus, and Japanese encephalitis virus.

LJI scientists are investigating new strategies for stopping Zika virus.